XXII Swings to Q3 Profit Amid Revenue Decline, Going Concern Doubts Persist

TL;DR

**XXII's Q3 profit is a mirage; declining revenue and a 'going concern' warning mean this stock is still a high-risk gamble.**

AI Summary

22nd Century Group, Inc. (XXII) reported a net income of $5.489 million for the three months ended September 30, 2025, a significant turnaround from a net loss of $3.757 million in the same period of 2024. However, for the nine months ended September 30, 2025, the company still posted a net loss of $2.246 million, though this is an improvement from the $10.608 million loss in the prior year. Revenue for the three months ended September 30, 2025, decreased to $4.011 million from $5.946 million in 2024, and for the nine months, it fell to $14.050 million from $20.361 million. The company's cash and cash equivalents increased to $4.846 million as of September 30, 2025, from $4.422 million at December 31, 2024, primarily due to $10.746 million in cash provided by financing activities, including $9.893 million from Series A preferred stock. Despite these financing efforts, the company reported negative cash flow from operations of $10.472 million for the nine months ended September 30, 2025, and an accumulated deficit of $396.117 million, leading management to express substantial doubt about its ability to continue as a going concern. The company also executed a 1-for-23 reverse stock split on June 20, 2025, as part of its efforts to regain Nasdaq compliance.

Why It Matters

For investors, the swing to a Q3 net income of $5.489 million is a positive signal, but the persistent 'going concern' doubt and declining revenues of $4.011 million raise serious questions about long-term viability. Employees face uncertainty given the company's ongoing losses and need for additional capital. Customers might see product availability impacted if the company struggles to secure financing. In the competitive tobacco market, 22nd Century Group's focus on reduced nicotine products, while unique, requires significant capital to scale, and its current financial state makes it vulnerable to larger, more established players.

Risk Assessment

Risk Level: high — The company explicitly states "substantial doubt about the Company's ability to continue as a going concern" due to significant losses and negative cash flows from operations, totaling $10.472 million for the nine months ended September 30, 2025. This is further evidenced by an accumulated deficit of $396.117 million as of September 30, 2025, despite recent financing activities.

Analyst Insight

Investors should exercise extreme caution and consider this a highly speculative investment. While the Q3 net income is a positive, the underlying operational challenges and explicit going concern warning suggest significant downside risk. Await clear evidence of sustained positive operating cash flow and revenue growth before considering a position.

Financial Highlights

debt To Equity

N/A

revenue

$4.011M

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

$5.489M

eps

N/A

gross Margin

N/A

cash Position

$4.846M

revenue Growth

-32.5%

Key Numbers

• $5.489M — Net Income (Q3 2025) (Significant turnaround from a $3.757M net loss in Q3 2024.)
• $4.011M — Revenue (Q3 2025) (Decreased from $5.946M in Q3 2024, indicating ongoing sales challenges.)
• $10.472M — Net Cash Used in Operations (9M 2025) (Continued negative cash flow, a primary driver of going concern doubt.)
• $396.117M — Accumulated Deficit (Sept 30, 2025) (Highlights historical unprofitability and financial strain.)
• $9.893M — Proceeds from Series A Preferred Stock (Key financing activity that boosted cash, but is not operational income.)
• 1-for-23 — Reverse Stock Split (Effected on June 20, 2025, to maintain Nasdaq listing compliance.)
• $4.846M — Cash and Cash Equivalents (Sept 30, 2025) (Slight increase from $4.422M at Dec 31, 2024, but still low given operating burn.)
• $2.246M — Net Loss (9M 2025) (Improved from $10.608M loss in 9M 2024, but still a loss.)

Key Players & Entities

• 22nd Century Group, Inc. (company) — registrant
• NASDAQ Capital Market (regulator) — exchange for common stock
• FDA (regulator) — authorized Modified Risk Tobacco Product
• $5.489 million (dollar_amount) — net income for Q3 2025
• $3.757 million (dollar_amount) — net loss for Q3 2024
• $4.011 million (dollar_amount) — revenue for Q3 2025
• $5.946 million (dollar_amount) — revenue for Q3 2024
• $10.472 million (dollar_amount) — net cash used in operating activities for nine months ended September 30, 2025
• $396.117 million (dollar_amount) — accumulated deficit as of September 30, 2025
• $9.893 million (dollar_amount) — net proceeds from Series A preferred stock

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: Management has expressed substantial doubt about the company's ability to continue as a going concern due to persistent operating losses and negative cash flow. The accumulated deficit stands at $396.117 million as of September 30, 2025, and the company reported negative cash flow from operations of $10.472 million for the nine months ended September 30, 2025.
• Dependence on Financing [high — financial]: The company's cash position is heavily reliant on financing activities, with $10.746 million in cash provided by financing activities for the nine months ended September 30, 2025, including $9.893 million from Series A preferred stock. This indicates a lack of sustainable operational cash generation.
• Declining Revenue Trends [medium — operational]: Revenue for the three months ended September 30, 2025, decreased to $4.011 million from $5.946 million in the prior year, and for the nine months, it fell to $14.050 million from $20.361 million. This downward trend suggests ongoing challenges in sales performance and market penetration.
• Nasdaq Compliance [medium — regulatory]: The company executed a 1-for-23 reverse stock split on June 20, 2025, to regain compliance with Nasdaq listing requirements. Failure to maintain compliance could lead to delisting, significantly impacting liquidity and investor confidence.

Industry Context

The tobacco and nicotine industry is undergoing significant transformation driven by evolving regulations and consumer preferences shifting towards reduced-risk products. Companies are investing heavily in R&D for next-generation products, facing intense competition from established players and emerging innovators. Regulatory scrutiny remains a constant challenge, impacting product development, marketing, and market access.

Regulatory Implications

XXII faces ongoing regulatory risks related to product development, marketing, and sales, particularly concerning its reduced-nicotine tobacco products. The company's efforts to regain Nasdaq compliance through a reverse stock split highlight the sensitivity of its stock performance to regulatory listing requirements.

What Investors Should Do

1. Monitor operational cash flow closely.
2. Assess the sustainability of revenue trends.
3. Evaluate the impact of financing activities.
4. Track Nasdaq compliance and stock performance.

Key Dates

• 2025-09-30: End of Q3 2025 — Reported net income of $5.489 million for the quarter, a significant improvement from the prior year's loss, but still a net loss of $2.246 million for the nine months. Cash and cash equivalents stood at $4.846 million.
• 2025-06-20: Reverse Stock Split — Executed a 1-for-23 reverse stock split to meet Nasdaq listing requirements, impacting share count and per-share metrics.
• 2024-09-30: End of Q3 2024 — Reported a net loss of $3.757 million for the quarter and $10.608 million for the nine months, with revenue of $5.946 million for the quarter.

Glossary

Accumulated Deficit

The total cumulative net losses of a company since its inception, less any cumulative net income. It represents a deficit in shareholders' equity. (Indicates the company's long-term unprofitability, standing at $396.117 million as of September 30, 2025.)

Going Concern

A business's ability to continue operating for the foreseeable future without the threat of liquidation. Auditors and management assess this regularly. (Management has expressed substantial doubt about XXII's ability to continue as a going concern, a critical warning for investors.)

Reverse Stock Split

A corporate action where a company reduces the total number of its outstanding shares by consolidating them. This increases the per-share price. (XXII implemented a 1-for-23 reverse split to comply with Nasdaq's minimum bid price rule.)

Series A Preferred Stock

A class of preferred stock that is typically issued early in a company's funding history, often with specific rights and preferences over common stock. (The issuance of Series A preferred stock provided $9.893 million in cash, a significant portion of the company's financing activities.)

Year-Over-Year Comparison

Compared to the prior year's nine months, 22nd Century Group (XXII) has shown an improvement in net loss, reducing it from $10.608 million to $2.246 million. However, this comes alongside a significant revenue decline, with nine-month revenues falling from $20.361 million to $14.050 million. While cash has slightly increased due to financing, the core operational cash burn remains a critical concern, and the accumulated deficit continues to be substantial.

Key Financial Figures

• $0.00001 — ange on Which Registered Common Stock, $0.00001 par value XXII NASDAQ Capital Marke
• $324 — capital raise, net of issuance costs of $324 1 639 — 3,913 — 3,913 — — S

Filing Documents

• xxii-20250930x10q.htm (10-Q) — 2659KB
• xxii-20250930xex31d1.htm (EX-31.1) — 12KB
• xxii-20250930xex31d2.htm (EX-31.2) — 12KB
• xxii-20250930xex32d1.htm (EX-32.1) — 10KB
• 0001104659-25-105922.txt ( ) — 11947KB
• xxii-20250930.xsd (EX-101.SCH) — 80KB
• xxii-20250930_cal.xml (EX-101.CAL) — 73KB
• xxii-20250930_def.xml (EX-101.DEF) — 376KB
• xxii-20250930_lab.xml (EX-101.LAB) — 595KB
• xxii-20250930_pre.xml (EX-101.PRE) — 531KB
• xxii-20250930x10q_htm.xml (XML) — 2382KB

Financial Statements

Financial Statements Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 (unaudited) 3 Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three and Nine Months ended September 30, 2025 and 2024 (unaudited) 4 Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) and Mezzanine Equity for the Three and Nine Months ended September 30, 2025 and 2024 (unaudited) 5 Condensed Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2025 and 2024 (unaudited) 6 Notes to Condensed Consolidated Financial Statements (unaudited) 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 32 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 41 Item 4.

Controls and Procedures

Controls and Procedures 42 PART II. OTHER INFORMATION 43 Item 1.

Legal Proceedings

Legal Proceedings 43 Item 1A.

Risk Factors

Risk Factors 43 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 43 Item 3. Default Upon Senior Securities 43 Item 4. Mine Safety Disclosures 43 Item 5. Other Information 43 Item 6. Exhibits 44

SIGNATURES

SIGNATURES 45 2 Table of Contents 22nd CENTURY GROUP, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (amounts in thousands, except share and per-share data) September 30, December 31, 2025 2024 ASSETS Current assets: Cash and cash equivalents $ 4,846 $ 4,422 Accounts receivable, net 2,993 1,698 Inventories 2,906 2,015 Insurance recoveries 9,500 768 GVB promissory note, net — 500 Prepaid expenses and other current assets 2,678 1,068 Current assets of discontinued operations held for sale — 1,051 Total current assets 22,923 11,522 Property, plant and equipment, net 2,452 2,773 Operating lease right-of-use assets, net 767 1,639 Intangible assets, net 6,210 5,724 Other assets 15 15 Total assets $ 32,367 $ 21,673 LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY Current liabilities: Notes and loans payable - current $ 368 $ 254 Current portion of long-term debt — 1,500 Operating lease obligations 163 261 Accounts payable 2,598 2,401 Accrued expenses 2,234 1,021 Accrued litigation — 768 Accrued payroll 140 318 Accrued excise taxes and fees 3,399 2,038 Deferred income 79 20 Other current liabilities 1,231 100 Current liabilities of discontinued operations held for sale 333 1,281 Total current liabilities 10,545 9,962 Long-term liabilities: Operating lease obligations 644 1,437 Long-term debt — 5,165 Other long-term liabilities 74 1,097 Total liabilities 11,263 17,661 Commitments and contingencies (Note 12) Mezzanine equity: Series A convertible preferred shares, $ 0.00001 par value; 9,650 shares issued and outstanding at September 30, 2025 and 0 at December 31, 2024, respectively 2,734 — Total mezzanine equity 2,734 — Shareholders' equity: Common stock, $ .00001 par value, 500,000,000 shares authorized, 6,987,290 shares issued and outstanding at September 30, 2025 an

View Full Filing

View this 10-Q filing on SEC EDGAR